TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
AML, Acute Myeloid Leukemia: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
eff↑, AntiThr↑, Bacteria↓, LDH↓, TumCP↓, TumCCA↑, Bcl-2↓, Cyt‑c↑, Casp3↑,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
THP1 |
|
|
|
Apoptosis↑, Casp7↑, PARP1↑, Bcl-2↓, Myc↓, CHOP↑, P21↑, p62↑, TumCCA↑, TXNIP↑, ROS↑, *antiOx↑, *Inflam↓, *neuroP↑, AntiCan↑, TumCP↓, angioG↓, TumMeta↓, VEGF↓, MMPs↓, tumCV↓, DNAdam↑, CHOP↑, cMyc↓, BioAv↓, Half-Life↓, BioAv↑,
TumCP↓, Apoptosis↑, ROS↑, NO↑, cl‑Bcl-2↑, BAX↑, MMP↓, Cyt‑c↑, AIF↑, Diablo↑, survivin↓, ICAD↓, Casp↑, cl‑PARP↑, DR4↑, TNFR 1↑,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Liver, |
Hep3B |
|
|
|
- |
in-vitro, |
AML, |
K562 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
TumCP↓, eff↑, other↝,
TumCP↓, TumCCA↑, TumCD↑, HSP90↓, HSP70/HSPA5↑, cycD1/CCND1↓, CDK4↓, CDK6↓, ATPase↓,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vivo, |
AML, |
NA |
|
|
|
TumCP↓, Apoptosis↑, TumCG↓, PDK1↓, cl‑PARP↑, Bcl-xL↓, Bcl-2↓, Beclin-1↓, ATG3↓, PI3K↓, Akt↓, eff↑,
| - |
vitro+vivo, |
AML, |
THP1 |
|
|
|
- |
in-vitro, |
AML, |
AMJ13 |
|
|
|
- |
vitro+vivo, |
lymphoma, |
HBL |
|
|
|
TumCP↓, TumAuto↑, IL1↓, NLRP3↓, Apoptosis↑, mtDam↑, P53↑, LDH↓,
ROS↑, other↑, p‑ERK↑, TumCP↓,
TumCP↓, BAX↑, Casp3↑, Bcl-2↓,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 3,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, MMP↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, LDH↓, 2, PDK1↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 4, BAX↑, 2, Bcl-2↓, 4, cl‑Bcl-2↑, 1, Bcl-xL↓, 1, Casp↑, 1, Casp3↑, 2, Casp7↑, 1, Cyt‑c↑, 2, Diablo↑, 1, DR4↑, 1, ICAD↓, 1, Myc↓, 1, survivin↓, 1, TNFR 1↑, 1, TumCD↑, 1,
Transcription & Epigenetics ⓘ
AntiThr↑, 1, other↑, 1, other↝, 1, tumCV↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 2, HSP70/HSPA5↑, 1, HSP90↓, 1,
Autophagy & Lysosomes ⓘ
ATG3↓, 1, Beclin-1↓, 1, p62↑, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP↑, 2, PARP1↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
p‑ERK↑, 1, PI3K↓, 1, TumCG↓, 1,
Migration ⓘ
ATPase↓, 1, MMPs↓, 1, TumCP↓, 9, TumMeta↓, 1, TXNIP↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, NO↑, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
IL1↓, 1,
Protein Aggregation ⓘ
NLRP3↓, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, eff↑, 3, Half-Life↓, 1,
Clinical Biomarkers ⓘ
LDH↓, 2, Myc↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 65
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Functional Outcomes ⓘ
neuroP↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page